Showing results (111-120 of 338) with videos related to
Sort By:
Pageof 34
Scientific Reports|July 27, 2016
Changes in the folding landscape of the WW domain provide a molecular mechanism for an inherited genetic syndromeEncarna Pucheta-Martinez, Nicola D'Amelio, Moreno Lelli, et al.Journal of the American Chemical Society|August 21, 2003
Fluorescent caged phosphoserine peptides as probes to investigate phosphorylation-dependent protein associationsM Eugenio Vázquez, Mark Nitz, Justine Stehn, et al.The Journal of Biological Chemistry|February 26, 2005
A structural basis for 14-3-3sigma functional specificityErik W Wilker, Robert A Grant, Stephen C Artim, et al.Nature Biotechnology|July 27, 2004
Caged phosphopeptides reveal a temporal role for 14-3-3 in G1 arrest and S-phase checkpoint functionAnhco Nguyen, Deborah M Rothman, Justine Stehn, et al.Molecular Biosystems|August 2, 2012
Robust co-regulation of tyrosine phosphorylation sites on proteins reveals novel protein interactionsKristen M Naegle, Forest M White, Douglas A Lauffenburger, et al.The Journal of Biological Chemistry|March 12, 2002
Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and -independent mechanismsBarbra A Johnson, Justine R Stehn, Michael B Yaffe, et al.Nature Communications|September 8, 2022
Multi-pathway DNA-repair reporters reveal competition between end-joining, single-strand annealing and homologous recombination at Cas9-induced DNA double-strand breaksBert van de Kooij, Alex Kruswick, Haico van Attikum, et al.Cancer Cell|February 13, 2007
p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damageH Christian Reinhardt, Aaron S Aslanian, Jacqueline A Lees, et al.The Journal of Investigative Dermatology|July 31, 2013
Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanomaFlore Nallet-Staub, Véronique Marsaud, Ling Li, et al.Bioorganic & Medicinal Chemistry Letters|September 4, 2018
Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitorsDavid Hymel, Robert A Grant, Kohei Tsuji, et al.Pageof 34